BioUtah News
-
Unveiling the Power of Epigenetics in Male Fertility: A New Horizon Beyond Semen Analysis
Unveiling the Power of Epigenetics in Male Fertility: A New Horizon Beyond Semen Analysis
-
Edwards receives CE mark for tricuspid valve replacement
The company expects to receive U.S. approval late next year.
-
Seek Labs Presents at the Animal Health, Nutrition & Technology Innovation Asia Summit in Tokyo, Japan
SALT LAKE CITY, UT, October, 18, 2023 – Seek Labs, a healthcare innovations company doing research in infectious…
-
DiscGenics Announces Research Collaboration with the U.S. Department of Veterans Affairs for Tissue-Engineered Discs with Discogenic Cells
Feasibility Project Awarded VA Technology Transfer Program BRAVE Funding Salt Lake City, UT – October 18, 2023 –…
-
BD Named Among the 100 Best Corporate Citizens of 2023
Company Ranks Top 2 in Healthcare Equipment and Services Industry
-
Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics
Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions
-
Why Antimicrobial Resistance Is Top of bioMérieux’s Diagnostic List
CLP Magazine recently interviewed Kristen Smith, senior medical science liaison at bioMérieux
-
Arcutis Presents Positive Patient-Reported Outcome Data from the Pivotal ARRECTOR Phase 3 Trial in Scalp and Body Psoriasis at European Academy of Dermatology and Venereology (EADV) Congress
Once-daily, steroid-free roflumilast foam 0.3% demonstrated significant improvements in both scalp and body psoriasis
-
ARUP Healthcare Advisory Services Wins a Third ASCP Choosing Wisely Champion Award
ARUP Healthcare Advisory Services Wins a Third ASCP Choosing Wisely Champion Award
-
Merit Medical Launches Expanded Maestro® Microcatheter Line
New multipurpose microcatheter length complements Merit’s radial-first legacy
-
GE HealthCare imaging CEO Jan Makela talks Mayo Clinic partnership
GE and Mayo Clinic plan to collaborate on imaging, artificial intelligence and cancer treatment.
-
US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix
-
National Institutes of Health Awards $45.1 Million NINDS Grant for CNM-Au8® Study in ALS
Funding to Support Research and Expanded Access of Investigational Drug in ALS SALT LAKE CITY, Oct. 05, 2023…
-
Owlet Commits Critical Support To Parents and Researchers On A Mission To End SIDS
LEHI, Utah–(BUSINESS WIRE)– Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT), a pioneer of smart baby monitoring, is…
-
New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood
New Myriad Genetics Survey Shows Breast Cancer Risk Factors Are Misunderstood
-
Medical Technology Company Focused on Vessel Preparation, Dilation, And Treatment Delivery Secures Series B Funding
Medical Technology Company Focused on Vessel Preparation, Dilation, And Treatment Delivery Secures Series B Funding
-
Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility
Biomerics Announces Completion of 100,000 sq. ft. Expansion of Brooklyn Park, MN, Facility
-
Audio-based Detection of Anxiety and Depression via Vocal Biomarkers
Audio-based Detection of Anxiety and Depression via Vocal Biomarkers
-
bioMérieux submits Dual 510(k) and CLIA-waiver application to FDA for the BIOFIRE® SPOTFIRE® Respiratory/Sore Throat (R/ST) Panel
Marcy-l’Étoile (France), September 22nd, 2023 – bioMérieux, a world leader in the field of in vitro diagnostics, has…
-
Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials
Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only test SALT LAKE CITY,…
-
Myriad Genetics Issues 2022 Environmental, Social and Governance Report
SALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic…
-
Rep. Moore’s Health Staff Visits Utah Life Sciences Companies
Rep. Moore’s Health Staff Tours Visits Utah Life Sciences Companies
-
Partnership and innovation help SSM Health secure lower-cost, reliable supply of generic drugs
Civica Rx, a health care utility co-founded by SSM Health, supplies critical medications that patients need.
-
GE HealthCare Awarded a $44 Million Grant to Develop Artificial Intelligence-Assisted Ultrasound Technology Aimed at Improving Outcomes in Low-and-Middle-Income Countries
rant from Bill & Melinda Gates Foundation will facilitate development of AI-assisted applications and tools
-
BioUtah, Life Sciences Innovators Take Stage at Legislature’s Interim Meeting
The Utah Life Sciences Innovation Caucus hosted a lunch for all legislators during the September 18.
-
NUSANO APPOINTS INDUSTRY EXPERT ALEXANDRE GIBIM AS CHIEF OPERATIONS OFFICER
EXECUTIVE WITH THREE DECADES OF SUCCESSFUL MULTINATIONAL OPERATIONS AND COMMERCIAL EXPERIENCE TO LEAD LAUNCH OF PROPRIETARY RADIOISOTOPE PRODUCTION…
-
BioUtah Participates in American Cancer Society Policy Panel Presentation
Kelvyn Cullimore, BioUtah’s CEO, participated as a panelist.
-
Merit Medical Launches the Aspira® Evacuated Drainage Bottle
Advanced design complements comprehensive drainage portfolio, expanding compassionate at-home treatment options to more patients
-
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
REC-3964 has been well tolerated in healthy volunteers with no reported serious adverse events. Recursion to explore initiating…
-
New Myriad Genetics Survey Reveals Widespread Confusion and Misconceptions About Ovarian Cancer Screening Among a Majority of Women
Nearly three out of four women falsely believe a pap smear will reveal ovarian cancer presence
-
Myriad Genetics Named to 2023 Best Workplaces in Health Care List by Fortune and Great Place To Work
Myriad Genetics announced Great Place To Work® and Fortune magazine have named Myriad Genetics to the 2023 Fortune…
-
Ultradent Named a Fortune Magazine Top Workplace for Third Straight Year
Ultradent Products is being recognized for the third consecutive year as a Fortune Magazine Top Large Workplace in…
-
Academia in Action: Searching for rare disease treatments
By their very nature, rare diseases impact a smaller portion of the population compared to conditions like cancer…
-
CLENE REPORTS SIGNIFICANTLY IMPROVED SURVIVAL BENEFIT OF 19.3 MONTHS AND SIGNIFICANTLY DELAYED CLINICAL WORSENING IN RESCUE-ALS OPEN-LABEL EXTENSION TWO YEAR FOLLOW-UP
19.3 month significant survival difference for CNM-Au8® treated participants versus placebo 52% significant decreased risk of ALS clinical…
-
BioTuesdays Features Halia Therapeutics CEO
In a recent interview with BioTuesdays, Halia and Co-Founder David Bearss, P.HD., said that the company is “growing…
-
Final Demolition Efforts Underway at The Point
Crews to topple final guard tower and showcase sustainable demolition practices WHAT: Members of the media are…
-
Halia Therapeutics Celebrates Grand Opening of Its Lehi, Utah Headquarters
It was standing room only Tuesday as Halia Therapeutics held a ribbon cutting for the opening of its…
-
Myriad Genetics and Onsite Women’s Health Partner to Help More Women Understand Breast Cancer Risk
New collaboration increases access to genetic testing and can help identify patients with a high-risk for breast cancer…
-
BlueWind Medical’s Revi™ System Secures U.S. FDA De Novo Classification Grant for the Treatment of Urgency Incontinence
Revi redefines the treatment of Urgency Incontinence with a patient-centric implantable tibial neuromodulation solution that empowers patients
-
Inherent Biosciences, Inc. Advances Fertility Solutions With Transformative Grant Funding From the NIH
A Leap Forward for Patients, a Promising Opportunity for Investors, and a Revolutionary Tool for Physicians
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8M Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial…
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
